[Purpose] We examined the incidence of cachexia at the beginning of rehabilitation in patients with advanced gastrointestinal cancer. [Participants and Methods] Patients with gastrointestinal cancer who were prescribed physical therapy and occupational therapy by their rehabilitation doctor and completed the survey item were targeted. We administered the cancer cachexia assessment and evaluated activities of daily living, and nutritional status in all participants. [Results] There were 15 patients in the normal group, 8 in the normal low-nutrition group, 16 in the pre-cachexia group, and 57 in the cachexia group. The cachexia group showed significantly lower nutritional status, and were less able to perform activities of daily living than the normal and pre-cachexia groups. [Conclusion] The incidence of cachexia among study participants was 17% in the pre-cachexia group and 59% in the cachexia group at the beginning of rehabilitation. Patients with advanced gastrointestinal cancer may have a higher incidence of cachexia at the beginning of rehabilitation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008023 | PMC |
| http://dx.doi.org/10.1589/jpts.32.16 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Anamorelin and Conduction Defects: A Literature Review and Analysis of the Japanese Pharmacovigilance Database.
In Vivo
December 2024
Department of Practical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan
Background/aim: Cancer cachexia is characterized by weight loss with a specific decrease in skeletal muscle and adipose tissue. In Japan, anamorelin, which has a novel mechanism of action, was approved in 2021 for the treatment of cancer cachexia. However, little information is available on its safety in routine clinical care, in particular the occurrence of conduction defects as adverse reactions.
View Article and Find Full Text PDFDistinct Gut Microbiota Profiles in Normal Weight Obesity and Their Association With Cardiometabolic Diseases: Results From Two Independent Cohort Studies.
J Cachexia Sarcopenia Muscle
February 2025
Chronic Disease Research Institute, the Children's Hospital, and National Clinical Research Center for Child Health, School of Public Health, School of Medicine, Zhejiang University, Hangzhou, China.
Background: Normal weight obesity (NWO) is characterized by excess body fat in individuals with normal body mass index (BMI). This study aimed to investigate gut microbiota alterations in NWO and their potential associations with cardiometabolic diseases (CMD) risk in two independent cohorts.
Methods: Our NWO-CMD mortality analysis included 168 099 adults with normal BMI from two large open-access databases, while our NWO-gut microbiota study involved 5467 adults with normal BMI from two independent cohorts: the WELL-China cohort and the Lanxi cohort.
Comparison Between Single- and Multi-slice Computed Tomography Body Composition Analysis in Patients With Oesophagogastric Cancer.
J Cachexia Sarcopenia Muscle
February 2025
Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK.
Article Synopsis
- This study investigates the effectiveness of single-slice versus multi-slice computed tomography (CT) methods in analyzing body composition in patients with oesophagogastric cancer, focusing on their correlation and impact on survival rates.
- Researchers examined CT scans of 504 patients, comparing measurements of skeletal muscle, subcutaneous, visceral, and intermuscular adipose tissue, finding high correlation and narrow limits of agreement between the two methods.
- Results indicate that both measurement techniques offer similar insights into body composition, suggesting that the clinical use of multi-slice analyses may be beneficial but requires further exploration for optimal application.
Characteristics of patients who die in an acute palliative care unit.
Support Care Cancer
December 2024
Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, 90127, Palermo, Italy.
Article Synopsis
- The study assessed characteristics and death risk factors for advanced cancer patients in an acute palliative care unit (APCU).
- Fifty-four out of 450 patients (12%) died in the APCU, with significant differences noted in aspects like cognitive decline, referral source, cachexia, and symptom burden between those who died and those who were discharged alive.
- Key factors linked to dying in APCU included being referred from home palliative care, experiencing high symptom burdens, and being off cancer treatment, indicating the need for improved end-of-life care strategies for these patients.
Pharmacist intervention and identification of adverse events related to treatment efficacy in cancer chemotherapy to improve clinical outcomes.
J Pharm Health Care Sci
December 2024
Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
Adverse events (AEs) induced by cancer chemotherapy reduce not only patient quality of life (QOL) but also the efficacy of treatment. Management of AEs can therefore improve both the efficacy and safety of cancer chemotherapy. This review describes the contribution of pharmacists to the management of adverse events aimed at improving the treatment efficacy of cancer chemotherapy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!